Medical College of Wisconsin
CTSICores SearchResearch InformaticsREDCap

C-Reactive Protein Monitoring Predicts Neutropenic Fever Following Autologous Hematopoietic Stem Cell Transplantation for Multiple Myeloma. Cureus 2018 Jul 08;10(7):e2945 PMID: 30202676 PMCID: PMC6128584

Pubmed ID

30202676

Abstract

Background Neutropenic fever (NF) is a known and common complication of autologous hematopoietic stem cell transplantation (ASCT). Early risk assessment may help direct treatment. We retrospectively analyzed the role of serial serum C-reactive protein (CRP) levels in predicting NF and assessed the clinical value of CRP within 14 days after transplantation. Methods One hundred twenty-one multiple myeloma (MM) patients received 170 first and/or second ASCT between January 2014 and March 2017. A Cox regression model was applied to assess the prognostic value of CRP as a time-dependent covariate at the onset of NF within 14 days post-transplant. Results Forty-seven of 170 patients developed NF. High CRP levels (4.0-43.2 mg/dL) were associated with a 5.45-fold increased risk of NF (P = 0.02). Patients had a nearly three-fold increased risk of NF after the second transplant (P < 0.01), but this was not associated with increased mortality. Those with NF had higher maximum values of CRP (P < 0.01) which tended to occur at or after the onset of NF. Conclusion CRP monitoring provides important information about the risk for NF immediately after first MM ASCT, and even more so after the second.

Author List

Kollu V, Mott SL, Khan R, Farooq U, Jethava Y, Dilek I, Tricot G

Author

Vidya Kollu MD Assistant Professor in the Medicine department at Medical College of Wisconsin




jenkins-FCD Prod-288 ba989beae37c4807010653a17407cd2d1f5e0810